Share on StockTwits

CombiMatrix (NASDAQ:CBMX) CFO Scott R. Burell bought 1,000 shares of the stock on the open market in a transaction that occurred on Wednesday, August 27th. The shares were purchased at an average cost of $2.04 per share, with a total value of $2,040.00. Following the completion of the transaction, the chief financial officer now directly owns 1,912 shares in the company, valued at approximately $3,900. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of CombiMatrix (NASDAQ:CBMX) traded down 5.08% on Monday, hitting $1.87. The stock had a trading volume of 511,992 shares. CombiMatrix has a one year low of $1.81 and a one year high of $4.44. The stock’s 50-day moving average is $2.13 and its 200-day moving average is $2.48. The company’s market cap is $20.7 million.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.

Receive News & Ratings for CombiMatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CombiMatrix and related companies with Analyst Ratings Network's FREE daily email newsletter.